Saturday, September 17, 2011

Martek Biosciences plans appeal of E.U. ruling on infant formula patent - Puget Sound Business Journal (Seattle):

takes-trendsthe.blogspot.com
That was word from the Columbia company Tuesdaty inregulatory filings. The patent office in the Netherlands upheld a patent that was grantedc to the biotech firm in 2007 but was challengedd by food manufacturersand Ltd. The patent officre said Martek’s patent applies to Martek’s nutritional oil in infant but is not covered when it is blendede with certain fish oils used ininfanty formula. Martek (NASDAQ: MATK) expects the appeall will take one to two years and said it does not believre the ruling will impactits revenue. Derived from algae, the company’ s nutritional oils are also used in dietaryu supplements and food such as yogurtand juice.
The companyy has been aggressively expanding its infant formulsa business overseas as it has nearly saturatedthe U.S. Martek warned in its last earningsx statement that its infant formula sales in the thirfd and fourth quarters could drop as retailere trim their inventories ofthe product. The company anticipatez demand will pick up infiscal 2010.

No comments:

Post a Comment